by Plus Therapeutics | Apr 25, 2024 | Uncategorized
“Plus Therapeutics’ commitment to revolutionizing cancer treatment extends beyond this latest award. With $23 million in active awards support, the company is at the forefront of targeted radiotherapeutic research. Moreover, ongoing trials, including...
by Plus Therapeutics | Apr 24, 2024 | LM
Thank you to everyone who came by our booth at #LBBCMetsConf this last weekend! If you missed us or would like to learn more about our Leptomeningeal Metastases clinical trial for Metastatic Breast Cancer patients, you can visit our website at...
by Plus Therapeutics | Apr 23, 2024 | PBC
Exciting news yesterday as $PSTV was able to share our recent $3 Million DoD Award for our ReSPECT-PBC Pediatric Brain Cancer Trial. Stock Region Article: https://bit.ly/4b4OBXG #Nasdaq #ClinicalResearch #ClinicalTrial #PediatricOncology...
by Plus Therapeutics | Apr 22, 2024 | PBC
BREAKING NEWS: Plus Therapeutics has been selected for funding by the Department of Defense (DoD) office of the Congressionally Directed Medical Research Programs (CDMRP). The award is expected to commence in Q3 2024 and will support the planned expansion of the...
by Plus Therapeutics | Apr 19, 2024 | LM
Come by our NEW booth at the Living Beyond Breast Cancer Metastatic Breast Cancer Conference this weekend! We have information about Leptomeningeal Metastases and our ongoing ReSPECT-LM Clinical Trial. See you there! 🎗️ ReSPECT-LM Website:...
Recent Comments